DOI QR코드

DOI QR Code

Inhibition of Metastasis and Invasion of Ovarian Cancer Cells by Crude Polysaccharides from Rosa Roxburghii Tratt in Vitro

  • Chen, Yang (Department of Biotechnology, Dalian Medical University) ;
  • Liu, Zhong-Jing (Department of Biotechnology, Dalian Medical University) ;
  • Liu, Jia (Department of Biotechnology, Dalian Medical University) ;
  • Liu, Li-Kun (Department of Biotechnology, Dalian Medical University) ;
  • Zhang, Er-Shao (Department of Biotechnology, Dalian Medical University) ;
  • Li, Wei-Ling (Department of Biotechnology, Dalian Medical University)
  • Published : 2015.01.06

Abstract

Background: Rosa Roxburghii Tratt is a promising wild fruit crop in Southwest China. Its extracts have been used as traditional Chinese medicine, which benefit immune responses and cure various health disorders. However, whether Rosa Roxburghii Tratt polysaccharides could inhibit metastasis and invasion of ovarian cancer cells remains unknown. Materials and Methods: Effects of crude polysaccharides from Rosa Roxburghii Tratt on the viability of ovarian cancer A2780 cells were detected by MTT assay. Ovarian carcinoma cell migration and invasion after exposure to Rosa Roxburghii Tratt polysaccharides were quantified by wound healing and Transwell assays, respectively. Western blotting was applied to assess protein levels of MMP-9. Results: The results indicated that Rosa Roxburghii Tratt polysaccharides significantly reduced wound closure rate of A2780 cells, inhibited their migration and invasion, and suppressed the expression of MMP-9. Conclusions: Our findings indicated that Rosa Roxburghii Tratt polysaccharides have potential for develop as anti-metastatic cancer drug preparations for ovarian cancer patients.

Keywords

Rosa roxburghii tratt polysaccharides;ovarian cancer;metastasis;MMP-9

Acknowledgement

Supported by : The Chinese National Natural Science Fund

References

  1. Alabsi AM, Ali R, Ali AM, et al (2013). Induction of caspase-9, biochemical assessment and morphological changes caused by apoptosis in cancer cells treated with goniothalamin extracted from Goniothalamus macrophyllus. Asian Pac J Cancer Prev, 14, 6273-80. https://doi.org/10.7314/APJCP.2013.14.11.6273
  2. Arikan SK, Kasap B, Yetimalar H, et al (2014). Impact of prognostic factors on survival rates in patients with ovarian carcinoma. Asian Pac J Cancer Prev, 15, 6087-94. https://doi.org/10.7314/APJCP.2014.15.15.6087
  3. Dinh P, Harnett P, Piccart-Gebhart MJ, et al (2008). New therapies for ovarian cancer: cytotoxics and molecularly targeted agents. Crit Rev Oncol Hematol, 67, 103-12. https://doi.org/10.1016/j.critrevonc.2008.01.012
  4. Goff BA, Mandel LS, Drescher CW, et al (2007). Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer, 109, 221-7. https://doi.org/10.1002/cncr.22371
  5. Himelstein BP, Canete-Soler R, Bernhard EJ, et al (1994). Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metastasis, 14, 246-58.
  6. Hsu YL, Kuo PL, Lin LT, et al (2005). Isoliquiritigenin inhibits cell proliferation and induces apoptosis in human hepatoma cells. Planta Med, 71, 130-4. https://doi.org/10.1055/s-2005-837779
  7. Hu X, Li D, Zhang W, et al (2012). Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion. Arch Gynecol Obstet, 286, 1537-43. https://doi.org/10.1007/s00404-012-2456-6
  8. Huang M, Xu Q, Deng XX (2014). l-Ascorbic acid metabolism during fruit development in an ascorbate-rich fruit crop chestnut rose (Rosa roxburghii Tratt). J Plant Physiol, 171, 1205-16. https://doi.org/10.1016/j.jplph.2014.03.010
  9. Jemal A, Siegel R, Ward E, et al (2008). Cancer statistics, 2008. CA Cancer J Clin, 58, 71-96. https://doi.org/10.3322/CA.2007.0010
  10. Kanazawa M, Satomi Y, Mizutani Y, et al (2003). Isoliquiritigenin inhibits the growth of prostate cancer. Eur Urol, 43, 580-6. https://doi.org/10.1016/S0302-2838(03)00090-3
  11. Kessenbrock K, Plaks V, Werb Z (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell, 141, 52-67. https://doi.org/10.1016/j.cell.2010.03.015
  12. Li LN, Zhou X, Gu Y, et al (2013). Prognostic value of MMP-9 in ovarian cancer: a meta-analysis. Asian Pac J Cancer Prev, 14, 4107-13. https://doi.org/10.7314/APJCP.2013.14.7.4107
  13. Liotta LA, Stetler-Stevenson WG (1990). Metalloproteinases and cancer invasion. Semin Cancer Biol, 1, 99-106.
  14. Liu W, Li SY, Huang XE, et al (2012). Inhibition of tumor growth in vitro by a combination of extracts from Rosa roxburghii Tratt and Fagopyrum cymosum. Asian Pac J Cancer Prev, 13, 2409-14. https://doi.org/10.7314/APJCP.2012.13.5.2409
  15. Ma YX, Zhu Y, Wang CF, et al (1997). The aging retarding effect of 'Long-Life CiLi'. Mech Ageing Dev, 96, 171-80. https://doi.org/10.1016/S0047-6374(97)01890-3
  16. Parmo-Cabanas M, Molina-Ortiz I, Matias-Roman S, et al (2006). Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes. J Pathol, 208, 108-18. https://doi.org/10.1002/path.1876
  17. Sengupta A, Ghosh S, Das S (2001). Modulation of DMBA induced genotoxicity in bone marrow by quercetin during skin carcinogenesis. J Exp Clin Cancer Res, 20, 131-4.
  18. Shan Z, Feng-Nian R, Jie G, et al (2012). Effects of valproic acid on proliferation, apoptosis, angiogenesis and metastasis of ovarian cancer in vitro and in vivo. Asian Pac J Cancer Prev, 13, 3977-82. https://doi.org/10.7314/APJCP.2012.13.8.3977
  19. Siegel R, Ma J, Zou Z, et al (2014). Cancer statistics, 2014. CA Cancer J Clin, 64, 9-29. https://doi.org/10.3322/caac.21208
  20. Stallings-Mann M, Radisky D (2007). Matrix metalloproteinaseinduced malignancy in mammary epithelial cells. Cells Tissues Organs, 185, 104-10. https://doi.org/10.1159/000101310
  21. Sun ZL, Tang YJ, Wu WG, et al (2013). AZD1480 can inhibit the biological behavior of ovarian cancer SKOV3 cells in vitro. Asian Pac J Cancer Prev, 14, 4823-7. https://doi.org/10.7314/APJCP.2013.14.8.4823
  22. Vaughan S, Coward JI, Bast RC, et al (2011). Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer, 11, 719-25. https://doi.org/10.1038/nrc3144
  23. Yang X, Lv Y, Tian L, et al (2010). Composition and systemic immune activity of the polysaccharides from an herbal tea (Lycopus lucidus Turcz). J Agric Food Chem, 58, 6075-80. https://doi.org/10.1021/jf101061y
  24. Zhang C, Liu X, Qiang H, et al (2001). Inhibitory effects of Rosa roxburghii tratt juice on in vitro oxidative modification of low density lipoprotein and on the macrophage growth and cellular cholesteryl ester accumulation induced by oxidized low density lipoprotein. Clin Chim Acta, 313, 37-43. https://doi.org/10.1016/S0009-8981(01)00647-7

Cited by

  1. Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer vol.10, pp.7, 2015, https://doi.org/10.1371/journal.pone.0132579
  2. Chemical Analysis of Dietary Constituents in Rosa roxburghii and Rosa sterilis Fruits vol.21, pp.9, 2016, https://doi.org/10.3390/molecules21091204
  3. Therapeutic Applications of Rose Hips from Different Rosa Species vol.18, pp.6, 2017, https://doi.org/10.3390/ijms18061137
  4. Ultrasound-assisted extraction, characterization, and antioxidant activity in vitro and in vivo of polysaccharides from Chestnut rose (Rosa roxburghii tratt) fruit vol.55, pp.3, 2018, https://doi.org/10.1007/s13197-017-3023-8
  5. Tratt fruit and its α-glucosidase inhibitory activity vol.9, pp.7, 2018, https://doi.org/10.1039/C8FO00561C